{"id":22875,"date":"2024-05-23T09:46:07","date_gmt":"2024-05-23T13:46:07","guid":{"rendered":"https:\/\/medicarereport.org\/?p=22875"},"modified":"2024-05-23T09:46:08","modified_gmt":"2024-05-23T13:46:08","slug":"biotechs-turn-to-gene-silencing-for-obesity-drugs-that-can-last-longer-than-wegovy","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=22875","title":{"rendered":"Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy"},"content":{"rendered":"\n<p><em>By<\/em>\u00a0 Allison DeAngelis\u00a0<a href=\"https:\/\/twitter.com\/ADeAngelis_bio\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a>\u00a0<em>and<\/em>\u00a0 Elaine Chen\u00a0<a href=\"https:\/\/twitter.com\/elaineywchen\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a>May 23, 2024 for Stat News<\/p>\n\n\n\n<p>Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference. <a href=\"https:\/\/www.statnews.com\/2024\/05\/23\/weight-loss-drugs-rna-interference-gene-silencing-regeneron\/\">Here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"113\" class=\"wp-image-7807\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/Microscope.jpg\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/Microscope.jpg 700w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/Microscope-300x225.jpg 300w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p><strong>Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><a href=\"https:\/\/twitter.com\/intent\/tweet?url=https:\/\/www.statnews.com\/2024\/05\/23\/weight-loss-drugs-rna-interference-gene-silencing-regeneron\/&amp;via=statnews&amp;text=Biotechs%20turn%20to%20gene%20silencing%20for%20obesity%20drugs%20that%20can%20last%20longer%20than%20Wegovy\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By\u00a0 Allison DeAngelis\u00a0\u00a0and\u00a0 Elaine Chen\u00a0May 23, 2024 for Stat News Enticed by the immense market opened by GLP-1 weight loss<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,15],"tags":[1335],"class_list":["post-22875","post","type-post","status-publish","format-standard","hentry","category-health-care-general","category-part-dprescription-drugs","tag-biotech-obesity-amacfoundation"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22875"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22875\/revisions"}],"predecessor-version":[{"id":22876,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22875\/revisions\/22876"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}